MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A case of idiopathic lower limb dystonia treated with combined use of botulinum toxin type A and phenol nerve block

    E. Bianchini, A. Massimiani, J. Bemporad, M. Giovannelli (Rome, Italy)

    Objective: Here we report a case of focal LLD successfully treated with combined botulinum neurotoxin type A (BoNTA) and Nerve block (NB). Background: Among focal dystonias,…
  • 2023 International Congress

    Correlation between rem sleep disorders and neurocognitive defects in patients with parkinson´s disease

    M. Castillo, A. Mariñez, J. Duran, I. Joga, A. Morales (santo domingo, Dominican Republic)

    Objective: The objective of the following study was to verify the correlation between cognitive disordersand REM sleep disorders. Background: REM sleep disorder affect a large…
  • 2023 International Congress

    Unveiling the role of subthalamic nucleus stimulation on freezing of gait in Parkinson disease using wearable sensors

    R. Barbosa, P. Pita Lobo, A. Valadas, P. Bastos, S. Alberto, L. Correia Guedes, M. Rosa, R. Matias, M. Coelho (Toulouse, France)

    Objective: Objectives: To determine whether Deep Brain Stimulation on the Subthalamic nucleus (STN-DBS) is responsible for post-surgery de novo On-State Freezing-of-Gait (FOG) in PD patients, and…
  • 2023 International Congress

    Cognitive overlap between Parkinson disease (PD) and Alzheimer’s disease (AD) is associated with plasma biomarkers and their impact on regional cortical thickness (CT): An ONDRI Study

    M. Masellis, G. Coughlan, P. Zhukovsky, E. Sanchez, D. Munoz, R. Buckley, T. Steeves, P. Mclaughlin, D. Grimes, M. Jog, C. Marras, H. Zetterberg, H. Kvartsberg, M. Binns, SE. Black, AE. Lang (Toronto, Canada)

    Objective: To investigate cognitive performance across the Parkinson-Alzheimer’s spectrum and its association with plasma biomarkers and regional CT. Background: While PD and AD are neurodegenerative…
  • 2023 International Congress

    self-compassion, trait worry and sleep in parkinson’s disease (PD) patients

    M. Cusnir, S. Diaconu, E. Ungureanu, B. Ciopleiasb, R. Zosin, I. Murasan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to evaluate possible interactions between measures ofself-compassion, trait worry and sleep in Parkinson’s Disease (PD) patients. Background: PD patients often experience states of persistent…
  • 2023 International Congress

    Relevance of amyloid deposition for REM sleep behavior disorder in Parkinson’s disease

    J. Pineda-Pardo, M. López-Aguirre, G. Pagano, V. Gnoni, K. Ray Chaudhuri, G. Logroscino, D. Urso (Madrid, Spain)

    Objective: In this study, we aimed to investigate the relationship between regional [18F]florbetaben PET binding to amyloid-β (Aβ) and REM sleep behavior disorder (RBD) in…
  • 2023 International Congress

    Reliability of Indonesian Version Wearing Off Questionnaire

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: This study measure the reliability of Indonesia version wearing off (WO) questionnaire for PD patients. Background: The wearing off phenomenon is disabling complication of…
  • 2023 International Congress

    Huntington disease-like: an atypical presentation of Niemann-Pick type C.

    MB. Charra Castellani, V. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Report a case of adult-onset Niemann-Pick disease type C (NPC) with Huntington disease-like (HDL) phenotype. Background: NPC is a neurodegenerative autosomal recessive lysosomal storage…
  • 2023 International Congress

    Correlates of gait impairment in parkinson’s disease

    E. Abdeldayem, A. Shalash (Cairo, Egypt)

    Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…
  • 2023 International Congress

    Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

    M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)

    Objective: to determine the potential differences in gait characteristics between PD-GBA carriers and non-carriers (idiopathic Parkinson’s disease (iPD)), both mutually and in relation to MSA-P.…
  • « Previous Page
  • 1
  • …
  • 453
  • 454
  • 455
  • 456
  • 457
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley